自动提醒改善瓣膜性心脏病的及时评估与治疗:ALERT试验
ALERT是一项多系统整群随机临床试验,纳入5个美国卫生系统35家医院中开具超声心动图的765名临床医生,1:1随机接受自动电子临床通知提醒或常规诊疗。主要终点为瓣膜干预时间与90天内多学科心脏团队评估时间的层次复合终点,提醒组优于常规诊疗(胜率比1.27,95%CI 1.05-1.54,P=0.007)。
要点
- 自动电子提醒可提高显著AS和MR患者的瓣膜干预率及心脏团队评估率。
- 提醒组瓣膜干预13.4% vs 9.6%,心脏团队评估22.7% vs 17.9%,差异均有统计学意义。
- AS与MR患者效果相似,各预设亚组未见异质性。
核心结论
- 在多系统整群随机试验中,自动电子临床通知提醒改善了临床显著AS和MR的及时指南导向评估与瓣膜干预。
- 电子健康记录整合的临床决策支持可能是减少治疗不足、改善专科瓣膜诊疗可及性的可扩展策略。
研究设计与样本
- ALERT为多系统整群随机临床试验,纳入5个美国卫生系统35家医院中开具超声心动图的临床医生。
- 2024年8月至2025年9月期间,765名临床医生按1:1随机接受自动电子临床通知提醒或常规诊疗,共涉及2016份超声心动图。
- 主要终点为至外科或经导管瓣膜干预时间、随后至90天内多学科心脏团队门诊评估时间的层次复合终点,采用分层胜率法分析。
主要发现
- 主要终点胜率比1.27(95%CI 1.05-1.54,P=0.007),提醒组优于常规诊疗。
- 瓣膜干预率13.4% vs 9.6%(P=0.005),多学科心脏团队评估率22.7% vs 17.9%(P=0.005),且两个终点组分时间均更短。
- AS患者胜率比1.29,MR患者胜率比1.23;瓣膜病理异质性检验Pint=0.821。
- 预设亚组(年龄、性别、种族、社会剥夺指数、住院与门诊、提供者专科、城乡)异质性检验Pint均>0.100。
- 改良意向治疗、意向治疗和符合方案人群的敏感性分析结果一致。
临床怎么用
- 可将电子健康记录整合的自动提醒用于识别显著AS和MR患者并推送诊疗建议,以促进及时评估和瓣膜干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Severe aortic stenosis (AS) and mitral regurgitation (MR) are frequently undertreated and characterized by persistent sex, racial and ethnic, socioeconomic, and geographic disparities despite effective valve therapies. Whether automated electronic clinician notification (ECN) alerts improve the evaluation and treatment of AS and MR across health systems is unknown. OBJECTIVES: The purpose of this study was to evaluate whether ECN alerts improve guideline-directed evaluation and treatment of significant AS and MR across multiple health systems. METHODS: ALERT is a multisystem, cluster-randomized clinical trial including clinicians ordering echocardiograms across 5 U.S. health systems encompassing 35 hospitals between August 2024 and September 2025. Clinicians were randomized 1:1 to receive an ECN alert identifying significant AS or MR with accompanying care recommendations or to no alert with usual care. The primary endpoint was a hierarchical composite of time to surgical or transcatheter valve intervention, followed by time to multidisciplinary heart team clinic evaluation within 90 days, analyzed using the stratified win-ratio method. Secondary outcomes included individual components of the composite. RESULTS: A total of 765 clinicians ordering 2,016 echocardiograms were included. In the win-ratio analysis of the primary endpoint, ECN alert was superior to usual care (win ratio: 1.27; 95% CI: 1.05-1.54; P = 0.007), including higher rates of valve intervention (13.4% vs 9.6%; P = 0.005) and multidisciplinary heart team evaluation (22.7% vs 17.9%; P = 0.005) and shorter times to both endpoint components. Effect sizes were similar in AS (win ratio: 1.29) and MR patients (win ratio: 1.23). No evidence of heterogeneity was noted by valve pathology (Pint = 0.821) or across prespecified subgroups (age, sex, race, social deprivation index, inpatient vs outpatient setting, provider specialty, and rurality; Pint > 0.100 for all) and sensitivity analyses yielded consistent results across modified intention-to-treat, intention-to-treat, and per-protocol populations. CONCLUSIONS: In this multisystem cluster randomized trial, automated ECN alerts improved timely guideline-directed evaluation and valve intervention for clinically significant AS and MR. These findings suggest that electronic health record-integrated clinical decision support may represent a scalable strategy to reduce undertreatment and improve access to specialized valve care. (Addressing Under-treatment and Health Equity in AS and MR Using an Integrated EHR Platform; NCT06099665).
引用
- Batchelor WB, Lindman BR, Coylewright M, et al. Automated Alerts to Improve Timely Evaluation and Treatment of Valvular Heart Disease: The ALERT Trial. J Am Coll Cardiol. 2026. PMID: 42059855. doi:10.1016/j.jacc.2026.03.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。